Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatrics

Medical Management, Screening, and Therapies

At a Glance

Medical management for 7q11.23 microduplication syndrome requires a multidisciplinary care team. Essential early steps include baseline cardiac and neurological evaluations, targeted speech therapy for motor-planning, and parental genetic testing to check for inherited traits.

Home

Because 7q11.23 microduplication syndrome (Dup7) affects multiple systems in the body, care is rarely managed by a single doctor. Instead, families typically build a multidisciplinary care team to address the “whole child.” While symptoms vary, initial recommendations focus on identifying potential heart, brain, and developmental needs early [1][2].

Initial Medical Screenings

Upon diagnosis, several baseline evaluations are generally recommended to rule out common physical complications:

  • Cardiac Evaluation: A baseline echocardiogram (heart ultrasound) is a priority. Doctors look specifically for aortic root dilation (a widening of the main artery) [3][1]. Sometimes, cardiologists measure the STJ-to-annulus ratio—which is simply a way of comparing the size of different parts of the aorta to see if it is stretching too much. If your child does have aortic dilation, be sure to ask your cardiologist if there are any restrictions on physical activities or sports.
  • Neurological Assessment: Because children with Dup7 often have macrocephaly (a larger head size), a pediatric neurologist will likely perform an evaluation [4]. Note: While a Brain MRI can check for structural differences (like fluid in the brain, called ventriculomegaly), it is not a mandatory baseline screening for all children. Because an MRI usually requires general anesthesia for young children, a neurologist will typically only order one if there are additional clinical red flags (like seizures or severe motor delays) to avoid unnecessary sedation risks [4][5].
  • Growth and Development Monitoring: Regular check-ins with a Developmental Pediatrician are vital for tracking growth milestones and coordinating complex care across different specialists [1][6].

Building Your Therapy Team

Therapy is often the most active part of a child’s daily life. A core team usually includes:

  1. Speech-Language Pathologist (SLP): This is often the most critical member of the team. Because of the high risk for Childhood Apraxia of Speech (CAS), therapy should focus on motor-planning—helping the brain tell the mouth how to move—rather than just learning new words [6][7].
  2. Occupational Therapist (OT): OTs help with hypotonia (low muscle tone) and sensory processing, helping your child gain independence in daily tasks like eating, dressing, or writing [1].
  3. Behavioral Therapist / Mental Health Professional: Finding the right behavioral support is crucial, but approaches must be tailored carefully:
    • For Autism Spectrum Disorder (ASD), neurodiversity-affirming behavioral therapies or Occupational Therapy can help your child navigate a world designed for neurotypical brains.
    • For Social Anxiety or Selective Mutism, avoid compliance-based approaches (like standard ABA), which can sometimes worsen anxiety. Instead, look for a specialist in Cognitive Behavioral Therapy (CBT) or specialized mutism interventions like PCIT-SM (Parent-Child Interaction Therapy for Selective Mutism) [6][8].

The Importance of Parental Testing

Determining whether the duplication was inherited or occurred de novo (randomly) is a vital step for the entire family [2][9].

  • Recurrence Risk: If a parent also carries the duplication, there is a 50% chance of passing it to future children [1].
  • Family Health: Some parents may have the duplication with very few symptoms, but knowing they have it ensures they get access to their own health screenings, such as cardiac monitoring [2][10].

Actionable Steps for Families

  • Request a “Medical Home”: Ask your pediatrician to act as the central “hub” for all specialist reports to ensure everyone is working from the same information [11].
  • Start Therapy Early: Research shows that early intervention in speech and behavioral health significantly improves long-term outcomes for children with Dup7 [1][6].
  • Monitor Puberty: As your child grows, be aware that Dup7 can be associated with delayed puberty, which may eventually require a visit to a pediatric endocrinologist [12].

Common questions in this guide

What baseline medical screenings are needed for 7q11.23 microduplication syndrome?
Children newly diagnosed with Dup7 should have an echocardiogram to check for aortic root dilation. A neurological assessment is also highly recommended to evaluate head size and track overall developmental milestones.
Why is speech therapy so important for children with Dup7?
Children with 7q11.23 microduplication have a high risk of Childhood Apraxia of Speech (CAS). Therapy needs to focus on motor-planning to help the brain successfully tell the mouth how to move, rather than just teaching vocabulary.
Does my child need an MRI after a 7q11.23 microduplication diagnosis?
A brain MRI is not a mandatory baseline screening for all children with Dup7. Because MRIs usually require sedation in young children, neurologists typically only recommend one if there are additional clinical red flags like seizures or severe motor delays.
Should parents be genetically tested for the 7q11.23 duplication?
Yes, parents should be tested to determine if the duplication was inherited or occurred randomly. If a parent carries the duplication, it helps them access appropriate health screenings for themselves and understand the 50% recurrence risk for future pregnancies.
What kind of behavioral therapy works best for Dup7 syndrome?
Behavioral therapies should be tailored to the child's specific needs. Cognitive Behavioral Therapy (CBT) or specialized mutism interventions are often better for social anxiety than standard compliance-based therapies, which can sometimes worsen symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has our child had a baseline echocardiogram, and does their heart structure show any signs of aortic root dilation?
  2. 2.Are there any specific restrictions on sports or physical activities we should enforce based on my child's current heart scan?
  3. 3.Is my child's speech delay consistent with Childhood Apraxia of Speech (CAS), and do you recommend a specialist SLP for motor-planning?
  4. 4.What is our schedule for growth and developmental surveillance over the next 12 to 24 months?
  5. 5.Can you refer us to a genetic counselor to discuss the results of our parental testing and the risks for future children?
  6. 6.Are there specific behavioral signs we should be looking for at home that might suggest social anxiety or selective mutism?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    7q11.23 Duplication syndrome: Physical characteristics and natural history.

    Morris CA, Mervis CB, Paciorkowski AP, et al.

    American journal of medical genetics. Part A 2015; (167A(12)):2916-35 doi:10.1002/ajmg.a.37340.

    PMID: 26333794
  2. 2

    [Clinical and genetic analysis of ten Chinese pedigrees affected with 7q11.23 duplication syndrome].

    Shi P, Liu Y, Hou Y, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024; (41(2)):140-144 doi:10.3760/cma.j.cn511374-20221118-00799.

    PMID: 38311550
  3. 3

    Aortic Geometry in Patients with Duplication 7q11.23 Compared to Healthy Controls.

    Lechich KM, Zarate YA, Daily JA, Collins RT

    Pediatric cardiology 2020; (41(6)):1199-1205 doi:10.1007/s00246-020-02375-2.

    PMID: 32474735
  4. 4

    Familial 7q11.23 duplication with variable phenotype.

    Patil SJ, Salian S, Bhat V, et al.

    American journal of medical genetics. Part A 2015; (167A(11)):2727-30 doi:10.1002/ajmg.a.37226.

    PMID: 26109321
  5. 5

    7q11.23 microduplication syndrome: neurophysiological and neuroradiological insights into a rare chromosomal disorder.

    Castiglia L, Husain RA, Marquardt I, et al.

    Journal of intellectual disability research : JIDR 2018; (62(5)):359-370 doi:10.1111/jir.12457.

    PMID: 29266505
  6. 6

    Phenotype of 7q11.23 duplication: A family clinical series.

    Earhart BA, Williams ME, Zamora I, et al.

    American journal of medical genetics. Part A 2017; (173(1)):114-119 doi:10.1002/ajmg.a.37966.

    PMID: 27615053
  7. 7

    The 7q11.23 Microduplication Syndrome: A Clinical Report with Review of Literature.

    Abbas E, Cox DM, Smith T, Butler MG

    Journal of pediatric genetics 2016; (5(3)):129-40 doi:10.1055/s-0036-1584361.

    PMID: 27617154
  8. 8

    The Behavioral Phenotype of 7q11.23 Duplication Syndrome Includes Risk for Oppositional Behavior and Aggression.

    Klein-Tasman BP, Yund BD, Mervis CB

    Journal of developmental and behavioral pediatrics : JDBP 2022; (43(6)):e390-e398 doi:10.1097/DBP.0000000000001068.

    PMID: 35580312
  9. 9

    Mayer-Rokitansky-Küster-Hauser syndrome associated with 7q11.23 microduplication: A case report.

    da Cunha GCR, de Souza VS, Von Zuben M, et al.

    Global medical genetics 2025; (12(2)):100039 doi:10.1016/j.gmg.2025.100039.

    PMID: 40276154
  10. 10

    [Prenatal ultrasonographic manifestations and genetic diagnosis of nine fetuses with 7q11.23 duplication syndrome].

    Li P, Guo J, Che J, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024; (41(3)):266-270 doi:10.3760/cma.j.cn511374-20221117-00795.

    PMID: 38448012
  11. 11

    Health supervision for children and adolescents with 16p11.2 deletion syndrome.

    Chung WK, Herrera FF,

    Cold Spring Harbor molecular case studies 2023; (9(4)) doi:10.1101/mcs.a006316.

    PMID: 38050025
  12. 12

    Altered pubertal timing in 7q11.23 copy number variations and associated genetic mechanisms.

    Wei SM, Gregory MD, Nash T, et al.

    iScience 2024; (27(3)):109113 doi:10.1016/j.isci.2024.109113.

    PMID: 38375233

This page provides educational information on managing 7q11.23 microduplication syndrome. Always consult your pediatrician and multidisciplinary medical team for individualized screening and therapy decisions.

Get notified when new evidence is published on 7q11.23 microduplication syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.